Brussels, 19/07/2013 (Agence Europe) - A patent granted before the entry into force of the Agreement on Trade-Related Aspects of Intellectual Property (TRIPs) for the process of manufacture of a pharmaceutical product does not, after its entry into force, cover the actual invention of the product, because the invention comes under trade policy, which is an exclusive competence of the European Union, ruled the European Court of Justice on 18 July in case C-414/11.
The Court of Justice was...